Strategic Exit Ross & Company reportedly sold its assets to Witt/Kieffer in December 2025, with founder Larry Ross joining WittKieffer as Senior Partner. This signals a potential close of a funding-backed growth cycle and may open opportunities for continued executive recruitment partnerships or advisory services during post‑acquisition integrations.

Private Equity Focus The firm positions itself as a strategic talent partner for prominent private equity and venture capital clients, specializing in C-suite, Operating Partner, Board, and functional leadership roles for sponsor‑backed companies. This creates a target opportunity to offer PE‑focused leadership search, retention planning, and leadership due diligence services.

Healthcare Niche Specialization in healthcare and life sciences, with a track record of placing senior leadership. These domain strengths present upsell potential for portfolio company leadership searches, operating partner engagements, and board advisory services tailored to healthcare sponsors.

Conferences & Networks Founder and host of Healthcare Leaders (HCL), a platform convening investors and operators. This network access can be leveraged for lead generation, event sponsorships, and partnership opportunities to expand both client and candidate pipelines.

Revenue Scale & Growth Reported revenue range of $100M–$250M places Ross & Company as a mid‑market player with potential cross‑sell opportunities into larger PE portfolios and mixed‑footprint firms. Engagements around executive search, leadership advisory, and integration support could be proposed to expand wallet share with current sponsor clients and peers in the sector.